Standley Adamek
Family Medicine · Tigard, ORNPI 1144515230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $919 and has fallen 80.8% since, to $177 in 2025. Among family medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$538
- AbbVie$402
- Pfizer$267
- Novo Nordisk$253
- Boehringer Ingelheim$245
- GSK$239
- plus $2K from 29 others
What the payments were for
- Travel & lodging$642%
- Food & beverage$3,79498%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $538 |
| AbbVie(2 entities) | 25 | $402 |
| Pfizer | 15 | $267 |
| Novo Nordisk | 13 | $253 |
| Boehringer Ingelheim | 10 | $245 |
| GSK | 12 | $239 |
| Inspire Medical Systems, Inc. | 11 | $229 |
| AstraZeneca | 10 | $171 |
| Merck | 10 | $168 |
| Exact Sciences | 6 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $144 |
| Gilead | 6 | $133 |
| Amgen(2 entities) | 8 | $125 |
| Eisai Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $72 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Biohaven Pharmaceuticals, Inc. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Sanofi Pasteur Inc. | 2 | $42 |
| Shire North American Group Inc | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $31 |
| Lucid Diagnostics Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Baxter Healthcare | 1 | $28 |
| Kaleo, Inc. | 1 | $28 |
| Vertex | 1 | $26 |
| Novartis | 1 | $21 |
| Bausch Health US, LLC | 1 | $21 |
| Viiv Healthcare Company | 1 | $20 |
| Medtronic | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Si-bone, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$3,870 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,070 |
| LinzessLinaclotide | 12 | $6,259 |
| DexilantDexlansoprazole | 12 | $3,567 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,604 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $1,156 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,130 |
| Losartan Potassium | 50 | $725 |
| Atorvastatin Calcium | 43 | $590 |
| Chlorthalidone | 12 | $490 |
| Mirtazapine | 25 | $466 |
| Promethazine Hcl | 20 | $463 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $452 |
| Estradiol (Once Weekly)Estradiol | 11 | $432 |
| Lisinopril | 57 | $390 |
| Amlodipine Besylate | 53 | $378 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $267 | $7,07012 claims |
| AbbVieLinzess | $402 | $6,25912 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $144 | $3,56712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,221 family medicine providers in Oregon.
Other family medicine in Tigard
- Andrea TremaineTigard$3K
- Michael PhelpsTigard$3K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
- Robert GobboPortland$53K
- Kevin MillerSisters$39K
- Morris MaizelsCentral Point$25K
- Maureen MaysPortland$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.